Poland's Proteon Pharmaceuticals has secured a €21 million ($24.6m) investment to accelerate the commercialization of its bacteriophage-based products, which it says can reduce aquaculture’s reliance on antibiotics. [...]
Want to keep reading?
Sign up for a trial to have full access to our articles for 7 days!
Have an account? Log in here:
Enter the email address associated with your account. We'll send you instructions to reset your password.
We’ve sent a link to to change your password.
Please check your inbox to reset your password securely and easily.
redirecting...
